We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+6.6%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$220M
AUM Growth
+$21.9M
Cap. Flow
+$60M
Cap. Flow %
27.25%
Top 10 Hldgs %
29.91%
Holding
89
New
19
Increased
34
Reduced
13
Closed
20

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$3.92M
2
ISRG icon
Intuitive Surgical
ISRG
+$3.35M
3
SYK icon
Stryker
SYK
+$3.29M
4
RMD icon
ResMed
RMD
+$2.29M
5
UHS icon
Universal Health Services
UHS
+$2.12M

Top Sells

Rank Stock Value
1
SHPG
Shire pic
SHPG
+$4.71M
2
VTRS icon
Viatris
VTRS
+$3.87M
3
ELV icon
Elevance Health
ELV
+$2.87M
4
CFN
CAREFUSION CORPORATION
CFN
+$2.66M
5
FRX
FOREST LABORATORIES INC
FRX
+$2.58M

Sector Composition

Rank Sector Weight
1 Healthcare 89.08%
2 Energy 0.53%
3 Industrials 0.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HCA icon
1
HCA Healthcare
HCA
$88B
$8.46M 3.85%
120,000
+20,000
+20% +$1.32M
UHS icon
2
Universal Health Services
UHS
$10.4B
$8.36M 3.8%
80,000
+20,000
+33% +$2.12M
CYH icon
3
Community Health Systems
CYH
$405M
$8.22M 3.74%
181,500
+12,100
+7% +$503K
THC icon
4
Tenet Healthcare
THC
$20.4B
$6.83M 3.1%
115,000
-10,000
-8% -$558K
AGN
5
DELISTED
Allergan plc
AGN
$6.63M 3.02%
27,500
+7,500
+38% +$1.68M
COR icon
6
Cencora
COR
$60.5B
$6.18M 2.81%
80,000
+5,000
+7% +$380K
DGX icon
7
Quest Diagnostics
DGX
$25.6B
$5.66M 2.57%
93,200
+20,000
+27% +$1.23M
CAH icon
8
Cardinal Health
CAH
$54.5B
$5.24M 2.38%
70,000
-5,000
-7% -$364K
COV
9
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$5.19M 2.36%
60,000
+5,000
+9% +$443K
LH icon
10
Labcorp
LH
$24.9B
$5.03M 2.28%
57,502
+10,942
+24% +$989K
BIIB icon
11
Biogen
BIIB
$30B
$4.96M 2.26%
15,000
+5,000
+50% +$1.65M
MNK
12
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$4.96M 2.25%
55,000
+10,000
+22% +$782K
MCK icon
13
McKesson
MCK
$99.6B
$4.87M 2.21%
25,000
-5,000
-17% -$962K
SNN icon
14
Smith & Nephew
SNN
$13.6B
$4.63M 2.1%
137,500
+25,000
+22% +$872K
LPNT
15
DELISTED
LifePoint Health, Inc.
LPNT
$4.5M 2.04%
65,000
-18,660
-22% -$1.31M
EVHC
16
DELISTED
Envision Healthcare Holdings Inc
EVHC
$4.33M 1.97%
41,750
+4,208
+11% +$446K
AMGN icon
17
Amgen
AMGN
$205B
$4.21M 1.92%
+30,000
New +$3.92M
WBA
18
DELISTED
Walgreens Boots Alliance
WBA
$4.15M 1.89%
70,000
+20,000
+40% +$1.31M
ALXN
19
DELISTED
Alexion Pharmaceuticals
ALXN
$4.15M 1.88%
25,000
+10,000
+67% +$1.64M
CNC icon
20
Centene
CNC
$30.8B
$4.14M 1.88%
200,000
-40,000
-17% -$771K
JAZZ icon
21
Jazz Pharmaceuticals
JAZZ
$15.8B
$4.01M 1.82%
25,000
+8,100
+48% +$1.25M
HUM icon
22
Humana
HUM
$44.3B
$3.91M 1.78%
30,000
+15,000
+100% +$1.91M
RAD
23
DELISTED
Rite Aid Corporation
RAD
$3.87M 1.76%
40,000
+5,000
+14% +$646K
ZBH icon
24
Zimmer Biomet
ZBH
$18.6B
$3.72M 1.69%
38,110
-8,240
-18% -$810K
BMY icon
25
Bristol-Myers Squibb
BMY
$132B
$3.58M 1.63%
70,000
+10,000
+17% +$500K
1
2 3 4

Similar funds

RSF
Rik Saylor Financial Fairfield, Ohio $132M AUM 16.04% 1-Year Est. Return
VF
Visa Foundation San Francisco, California $132M AUM 14.62% 1-Year Est. Return
AFP
ATX Financial Planning Austin, Texas $132M AUM
GCM
Graver Capital Management Columbus, Ohio $132M AUM 16.79% 1-Year Est. Return
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
GCM
Gunpowder Capital Management Towson, Maryland $132M AUM
PF
PlanVest Financial Gaithersburg, Maryland $131M AUM
DQRIM
Dale Q Rice Investment Management Vancouver, Washington $132M AUM 45.8% 1-Year Est. Return

Sivik Global Healthcare's Q3 2014 Portfolio in Review

As of Q3 2014, Sivik Global Healthcare held 89 positions worth $220M, up 11% from $198M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Sivik Global Healthcare deployed $60M of net new capital in Q3 2014, opening 19 new positions and adding to 34 existing holdings. Its largest new stake was Amgen: 30,000 shares worth $4.21M.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets, up from 88% a quarter earlier, followed by Energy and Industrials.

On the sell side, the largest reduction was Elevance Health, an estimated $2.87M trimmed.

  • Sivik Global Healthcare's largest Q3 2014 buy was Amgen: 30,000 shares worth $4.21M.
  • Sivik Global Healthcare added most to Universal Health Services in Q3 2014, an estimated $2.12M increase.
  • Sivik Global Healthcare's biggest Q3 2014 reduction was Elevance Health, cutting an estimated $2.87M.
  • Sivik Global Healthcare fully exited Shire pic in Q3 2014, selling an estimated $4.71M.
  • Sivik Global Healthcare's ten largest holdings make up 30% of its $220M portfolio in Q3 2014.
  • Sivik Global Healthcare opened 19 new positions and closed 20 in Q3 2014.
  • Sivik Global Healthcare's portfolio value rose 11% quarter-over-quarter to $220M.

Based on Sivik Global Healthcare's 13F filing for Q3 2014, filed 3 Oct 2014.